SirPAD Study Results on Femoropopliteal PAD to be Presented at VIVA 2026

New results from the SirPAD randomized trial will be presented at VIVA 2026, focusing on patients with femoropopliteal peripheral artery disease causing intermittent claudication. The study compared angioplasty with a sirolimus-coated balloon to an uncoated balloon.